Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes

Journal of Vascular Surgery

Volumn 59, Issue 5, 2014, Pages 1291-1299

  Mueller, Thomas ^a   Hinterreiter, Franz ^b   Luft, Christian ^b   Poelz, Werner ^c   Haltmayer, Meinhard ^a   Dieplinger, Benjamin ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Department of Vascular Surgery Konventhospital Barmherzige Brueder ^*  (Austria)

^c JOHANNES KEPLER UNIVERSITY LINZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HUMAN; LEG AMPUTATION; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTOR VARIABLE; PRIORITY JOURNAL; STRATIFIED SAMPLE;

AGE FACTORS; AGED; AGED, 80 AND OVER; AUSTRIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COMORBIDITY; CRITICAL ILLNESS; DIABETES MELLITUS; FEMALE; HUMANS; ISCHEMIA; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; PATIENT ADMISSION; PEPTIDE FRAGMENTS; PERIPHERAL ARTERIAL DISEASE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84899512831     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2013.11.063     Document Type: Article

References (35)

1. J.I. Weitz, J. Byrne, G.P. Clagett, M.E. Farkouh, J.M. Porter, and D.L. Sackett et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review Circulation 94 1996 3026 3049
2. J.J. Belch, E.J. Topol, G. Agnelli, M. Bertrand, R.M. Califf, and D.L. Clement et al. Critical issues in peripheral arterial disease detection and management: a call to action Arch Intern Med 163 2003 884 892
3. F.G. Fowkes, D. Rudan, I. Rudan, V. Aboyans, J.O. Denenberg, and M.M. McDermott et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis Lancet 382 2013 1329 1340
4. A.T. Hirsch, and S. Duval The global pandemic of peripheral artery disease Lancet 382 2013 1312 1314
5. H.L. Gornik Peripheral arterial disease enters the biomarker era: does risk stratification tell us something that we don't already know? Eur Heart J 29 2008 150 152
6. N. Malyar, T. Fürstenberg, J. Wellmann, M. Meyborg, F. Lüders, and K. Gebauer et al. Recent trends in morbidity and in-hospital outcomes of in-patients with peripheral arterial disease: a nationwide population-based analysis Eur Heart J 34 2013 2706 2714
7. S. Haugen, I.P. Casserly, J.G. Regensteiner, and W.R. Hiatt Risk assessment in the patient with established peripheral arterial disease Vasc Med 12 2007 343 350
8. V. Aboyans, and M.H. Criqui Can we improve cardiovascular risk prediction beyond risk equations in the physician's office? J Clin Epidemiol 59 2006 547 558
9. T. Mueller, R. Marschon, B. Dieplinger, D. Haidinger, A. Gegenhuber, and W. Poelz et al. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study J Vasc Surg 41 2005 808 815
10. T. Mueller, B. Dieplinger, W. Poelz, G. Endler, O.F. Wagner, and M. Haltmayer Amino-terminal pro-B-type natriuretic peptide as predictor of mortality in patients with symptomatic peripheral arterial disease: 5-year follow-up data from the Linz Peripheral Arterial Disease Study Clin Chem 55 2009 68 77
11. D. Sacks, C.W. Bakal, P.T. Beatty, G.J. Becker, J.F. Cardella, and R.D. Raabe et al. Position statement on the use of the ankle brachial index in the evaluation of patients with peripheral vascular disease J Vasc Interv Radiol 14 2003 S389
12. E.G. Grant, C.B. Benson, G.L. Moneta, A.V. Alexandrov, J.D. Baker, and E.I. Bluth et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis: Society of Radiologists in Ultrasound Consensus Conference Radiology 229 2003 340 346
13. R.B. Rutherford, J.D. Baker, C. Ernst, K.W. Johnston, J.M. Porter, and S. Ahn et al. Recommended standards for reports dealing with lower extremity ischemia: revised version J Vasc Surg 26 1997 517 538
14. T. Mueller, B. Dieplinger, W. Poelz, and M. Haltmayer Increased pregnancy-associated plasma protein-A as a marker for peripheral atherosclerosis: results from the Linz Peripheral Arterial Disease study Clin Chem 52 2006 1096 1103
15. B. Dieplinger, W. Poelz, M. Haltmayer, and T. Mueller Hypoadiponectinemia is associated with symptomatic atherosclerotic peripheral arterial disease Clin Chem Lab Med 44 2006 830 833
16. B. Dieplinger, M. Haltmayer, W. Poelz, and T. Mueller Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) study Clin Chim Acta 408 2009 87 91
17. T. Mueller, B. Dieplinger, T. Forstner, W. Poelz, and M. Haltmayer Pregnancy-associated plasma protein-A as a marker for long-term mortality in patients with peripheral atherosclerosis: inconclusive findings from the Linz Peripheral Arterial Disease (LIPAD) study Clin Chem Lab Med 48 2010 537 542
18. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation: Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470
19. J. Dormandy, L. Heeck, and S. Vig The natural history of claudication: risk to life and limb Semin Vasc Surg 12 1999 123 137
20. O. Yousuf, B.D. Mohanty, S.S. Martin, P.H. Joshi, M.J. Blaha, and K. Nasir et al. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol 62 2013 397 408
21. J. Genest C-reactive protein: risk factor, biomarker and/or therapeutic target? Can J Cardiol 26 Suppl A 2010 41A 44A
22. M.M. McDermott, and D.M. Lloyd-Jones The role of biomarkers and genetics in peripheral arterial disease J Am Coll Cardiol 54 2009 1228 1237
23. P.M. Ridker Moving beyond JUPITER: will inhibiting inflammation reduce vascular event rates? Curr Atheroscler Rep 15 2013 295
24. P.M. Ridker, T. Thuren, A. Zalewski, and P. Libby Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) Am Heart J 162 2011 597 605
25. B.M. Everett, A.D. Pradhan, D.H. Solomon, N. Paynter, J. Macfadyen, and E. Zaharris et al. Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis Am Heart J 166 2013 199 207
26. M.R. Cowie, P. Jourdain, A. Maisel, U. Dahlstrom, F. Follath, and R. Isnard et al. Clinical applications of B-type natriuretic peptide (BNP) testing Eur Heart J 24 2003 1710 1718
27. R. Pfister, and C.A. Schneider Natriuretic peptides BNP and NT-pro-BNP: established laboratory markers in clinical practice or just perspectives? Clin Chim Acta 349 2004 25 38
28. C. Kistorp Risk stratification in secondary prevention: advances in multimarker profiles, or back to basics? Circulation 114 2006 184 186
29. R.W. Troughton, C.M. Frampton, T.G. Yandle, E.A. Espiner, M.G. Nicholls, and A.M. Richards Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 2000 1112 1113
30. P. Jourdain, G. Jondeau, F. Funck, P. Gueffet, A. Le Helloco, and E. Donal et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study J Am Coll Cardiol 49 2007 1733 1739
31. R.G. Anand, H.O. Ventura, and M.R. Mehra Is heart failure more prevalent in patients with peripheral arterial disease? A meta-analysis Congest Heart Fail 13 2007 319 322
32. C. Diehm, J.R. Allenberg, D. Pittrow, M. Mahn, G. Tepohl, and R.L. Haberl et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease Circulation 120 2009 2053 2061
33. W.S. Jones, K.M. Schmit, S. Vemulapalli, S. Subherwal, M.R. Patel, and V. Hasselblad et al. Treatment strategies for patients with peripheral artery disease. Comparative effectiveness review No. 118. (Prepared by the Duke Evidence-based Practice Center under Contract No. 290-2007-10066-I.) AHRQ Publication No. 13-EHC090-EF May 2013 Agency for Healthcare Research and Quality Rockville, MD Available at: www.effectivehealthcare.ahrq.gov/reports/final.cfm
34. D.J. Adam, J.D. Beard, T. Cleveland, J. Bell, A.W. Bradbury, and J.F. Forbes et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial Lancet 366 2005 1925 1934
35. E. Eskelinen, and M. Lepäntalo Role of infrainguinal angioplasty in the treatment of critical limb ischaemia Scand J Surg 96 2007 11 16